PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: Review of Canadian Economic Studies [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2011 Nov. (CADTH Optimal Use Report, No. 1.2B.)

8CONCLUSIONS

The costs of specialized anticoagulation services in Canada are uncertain.

Four studies reported data on the costs, health care resources, or cost-effectiveness of specialized anticoagulation services or patient self-management. These studies were limited by the duration of observation (six months or less), selection bias, incomplete capture of relevant costs, or use of a model based on uncertain clinical data.

Copyright © 2011 CADTH.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Cover of Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: Review of Canadian Economic Studies
Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: Review of Canadian Economic Studies [Internet].
CADTH Optimal Use Report, No. 1.2B.

Download

PubMed Health Blog...

read all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...